You just read:

Results from Investigational Studies of Boceprevir Presented at the Conference on Retroviruses and Opportunistic Infections to Understand Potential Use in Patients Coinfected with Chronic Hepatitis C and HIV-1

News provided by

Merck

Mar 06, 2012, 22:29 ET